Drug
[177Lu]Lu-PSMA I&T
[177Lu]Lu-PSMA I&T is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
recruiting375%
active_not_recruiting125%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_2
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
NCT05893381
active_not_recruitingphase_2
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
NCT05867615
recruitingphase_2
Neoadjuvant PSMA-RLT in Oligometastatic PCa
NCT06259123
recruitingphase_2
PSMA-RLT in Biochemically Recurrent PCa
NCT06220188
Clinical Trials (4)
Showing 4 of 4 trials
NCT05893381Phase 2
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
NCT05867615Phase 2
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:
NCT06259123Phase 2
Neoadjuvant PSMA-RLT in Oligometastatic PCa
NCT06220188Phase 2
PSMA-RLT in Biochemically Recurrent PCa
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4